VIDEO Results
1
-
10
of
684
for
huckman
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at ...
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Hea...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Barbara Ryan, pharma analyst at Deutsche Bank Securities, shares her reactio...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number could double over t...
The FDA is holding meetings into big pharma's possible use of social media to sell their products. CNBC's Mike Huckman has the details.
Big pharma is embracing social media, but how much can or should a tightly regulated sector be able to say on Facebook or Twitter? CNBC's Mi...
Sanofi Aventis confirms that kids 9 and under need not one but two H1N1 shots, with CNBC's Mike Huckman.
|
 |
